Company name
2022Founder
Rezo Therapeutics Rezo turns protein-protein interactions into drug targets, mapping disease networks with integrated biology and AI to design precision medicines.
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Data current as of November 17, 2022